Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Wells Fargo analyst Brandon Couillard maintains Bruker (NASDAQ:BRKR) with a Overweight and lowers the price target from $50 ...
TD Cowen analyst Dan Brennan maintains Bruker (NASDAQ:BRKR) with a Hold and raises the price target from $40 to $42.
UBS analyst Dan Leonard maintains Bruker (NASDAQ:BRKR) with a Neutral and raises the price target from $40 to $43.
Barclays analyst Luke Sergott maintains Bruker (NASDAQ:BRKR) with a Overweight and raises the price target from $40 to $45.
Wall Street opened the week on a mixed note on Monday.
Bruker Corp (BRKR) beats Q3 expectations with 45 cents per share, $860.5 million revenue, but reports decline compared to last ...
Bruker (NASDAQ:BRKR) lowers FY2025 Adj EPS guidance from $1.95-$2.05 to $1.85-$1.90 vs $1.96 analyst estimate. Lowers FY2025 sa...
Bruker (NASDAQ:BRKR) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.34 by 34.33...
